Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) has received a consensus recommendation of “Hold” from the eight brokerages that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price […]